What are the clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis?
The high prevalence of atrial fibrillation in cardiac amyloidosis, particularly the ATTR subtype, suggests that prospective screening for occult AF may be warranted in these patients.
Atrial fibrillation affects nearly half of all patients with CA. Patients presenting with AF have more severe symptoms and higher burden of comorbidities. ATTR type of amyloidosis is the strongest predictor of AF. Prospective screening for occult AF may be considered in ATTR-CA.
Παπαθανασίου et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: